The manufacturer of a breast cancer drug which has been deemed "too expensive" to be offered by the NHS has hit back at the decision.
Dr Jayson Dallas, general manager of Roche Products Limited, declared it "an incredible injustice."
Despite Roche offering a significant discount, we are once again disappointed that Nice has not shown any flexibility on access to Kadcyla.
Refusing patients access to this drug is an incredible injustice and tantamount to turning the clock back in cancer research and development. We plan to appeal this decision.
More top news
Michael Bond, the creator of Paddington Bear has died at the age of 91.
Theresa May said the number of high rises which have failed fire safety tests has risen to 120.
The pair faced each other in the first Prime Minister's Questions since the General Election.